Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Science (New York, N.Y.)
|
August 4, 2018
Unlocking P(V): Reagents for chiral phosphorothioate synthesis
Kyle W Knouse, Justine N deGruyter, Michael A Schmidt, et al.
Journal for Immunotherapy of Cancer
|
March 3, 2021
<i>LRP1B</i> mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types
Landon C Brown, Matthew D Tucker, Ramy Sedhom, et al.
The Oncologist
|
March 11, 2022
Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate Cancer
Meredith N Freeman, Albert Jang, Jason Zhu, et al.
Science Advances
|
December 5, 2020
Reliable, low-cost, fully integrated hydration sensors for monitoring and diagnosis of inflammatory skin diseases in any environment
Surabhi R Madhvapathy, Heling Wang, Jessy Kong, et al.
Journal for Immunotherapy of Cancer
|
October 17, 2022
Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinoma
Landon C Brown, Jason Zhu, Kunal Desai, et al.
The Prostate
|
April 1, 2021
Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer
Elisa M Ledet, Earle F Burgess, Alexandra O Sokolova, et al.
The Journal of Organic Chemistry
|
July 7, 2021
P(III) vs P(V): A P(V) Reagent for Thiophosphoramidate Linkages and Application to an Asymmetric Synthesis of a Cyclic Dinucleotide STING Agonist
Bin Zheng, Chao Hang, Jason Zhu, et al.
Oncoimmunology
|
September 14, 2020
Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients
Tian Zhang, Sarabjot Pabla, Felicia L Lenzo, et al.
Journal for Immunotherapy of Cancer
|
January 26, 2019
Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors
Jeffrey M Conroy, Sarabjot Pabla, Mary K Nesline, et al.
Journal for Immunotherapy of Cancer
|
February 3, 2019
Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients
Sarabjot Pabla, Jeffrey M Conroy, Mary K Nesline, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Science (New York, N.Y.)
|
August 4, 2018
Unlocking P(V): Reagents for chiral phosphorothioate synthesis
Kyle W Knouse, Justine N deGruyter, Michael A Schmidt, et al.
Journal for Immunotherapy of Cancer
|
March 3, 2021
<i>LRP1B</i> mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types
Landon C Brown, Matthew D Tucker, Ramy Sedhom, et al.
The Oncologist
|
March 11, 2022
Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate Cancer
Meredith N Freeman, Albert Jang, Jason Zhu, et al.
Science Advances
|
December 5, 2020
Reliable, low-cost, fully integrated hydration sensors for monitoring and diagnosis of inflammatory skin diseases in any environment
Surabhi R Madhvapathy, Heling Wang, Jessy Kong, et al.
Journal for Immunotherapy of Cancer
|
October 17, 2022
Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinoma
Landon C Brown, Jason Zhu, Kunal Desai, et al.
The Prostate
|
April 1, 2021
Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer
Elisa M Ledet, Earle F Burgess, Alexandra O Sokolova, et al.
The Journal of Organic Chemistry
|
July 7, 2021
P(III) vs P(V): A P(V) Reagent for Thiophosphoramidate Linkages and Application to an Asymmetric Synthesis of a Cyclic Dinucleotide STING Agonist
Bin Zheng, Chao Hang, Jason Zhu, et al.
Oncoimmunology
|
September 14, 2020
Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients
Tian Zhang, Sarabjot Pabla, Felicia L Lenzo, et al.
Journal for Immunotherapy of Cancer
|
January 26, 2019
Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors
Jeffrey M Conroy, Sarabjot Pabla, Mary K Nesline, et al.
Journal for Immunotherapy of Cancer
|
February 3, 2019
Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients
Sarabjot Pabla, Jeffrey M Conroy, Mary K Nesline, et al.
Page
of 7